Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

USA - NYSE:XPOF - US98422X1019 - Common Stock

8.92 USD
+0.17 (+1.94%)
Last: 9/12/2025, 8:26:36 PM
8.9 USD
-0.02 (-0.22%)
After Hours: 9/12/2025, 8:26:36 PM
Fundamental Rating

3

Overall XPOF gets a fundamental rating of 3 out of 10. We evaluated XPOF against 134 industry peers in the Hotels, Restaurants & Leisure industry. While XPOF is still in line with the averages on profitability rating, there are concerns on its financial health. XPOF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XPOF had negative earnings in the past year.
In the past year XPOF had a positive cash flow from operations.
XPOF had negative earnings in 4 of the past 5 years.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

With a Return On Assets value of -14.46%, XPOF is not doing good in the industry: 86.57% of the companies in the same industry are doing better.
XPOF has a better Return On Invested Capital (18.81%) than 91.04% of its industry peers.
The Average Return On Invested Capital over the past 3 years for XPOF is significantly below the industry average of 15.68%.
The 3 year average ROIC (10.38%) for XPOF is below the current ROIC(18.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -14.46%
ROE N/A
ROIC 18.81%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a Operating Margin of 21.52%. This is amongst the best in the industry. XPOF outperforms 82.09% of its industry peers.
XPOF has a better Gross Margin (76.81%) than 91.04% of its industry peers.
XPOF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.52%
PM (TTM) N/A
GM 76.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

XPOF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, XPOF has more shares outstanding
The number of shares outstanding for XPOF has been increased compared to 5 years ago.
XPOF has a worse debt/assets ratio than last year.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.63, we must say that XPOF is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.63, XPOF is doing worse than 90.30% of the companies in the same industry.
XPOF has a debt to FCF ratio of 40.17. This is a negative value and a sign of low solvency as XPOF would need 40.17 years to pay back of all of its debts.
XPOF has a Debt to FCF ratio (40.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 40.17
Altman-Z -0.63
ROIC/WACC1.74
WACC10.81%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 0.91. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
XPOF has a Current ratio (0.91) which is in line with its industry peers.
A Quick Ratio of 0.84 indicates that XPOF may have some problems paying its short term obligations.
The Quick ratio of XPOF (0.84) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.84
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

The earnings per share for XPOF have decreased strongly by -153.13% in the last year.
The Revenue has decreased by -2.84% in the past year.
XPOF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.93% yearly.
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%

3.2 Future

The Earnings Per Share is expected to grow by 169.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.88% on average over the next years.
EPS Next Y542%
EPS Next 2Y257.73%
EPS Next 3Y169.83%
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2Y0.04%
Revenue Next 3Y5.88%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XPOF. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.26, the valuation of XPOF can be described as reasonable.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaply inside the industry as 94.03% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of XPOF to the average of the S&P500 Index (22.73), we can say XPOF is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.26
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

73.88% of the companies in the same industry are more expensive than XPOF, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as XPOF.
Industry RankSector Rank
P/FCF 48.41
EV/EBITDA 9.24
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XPOF's earnings are expected to grow with 169.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y257.73%
EPS Next 3Y169.83%

0

5. Dividend

5.1 Amount

XPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (9/12/2025, 8:26:36 PM)

After market: 8.9 -0.02 (-0.22%)

8.92

+0.17 (+1.94%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners76.52%
Inst Owner Change-1.27%
Ins Owners3.65%
Ins Owner Change23.3%
Market Cap435.65M
Analysts80
Price Target12.58 (41.03%)
Short Float %13.68%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-13.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-101.56%
Min EPS beat(2)-219.74%
Max EPS beat(2)16.62%
EPS beat(4)1
Avg EPS beat(4)-116.42%
Min EPS beat(4)-219.74%
Max EPS beat(4)16.62%
EPS beat(8)1
Avg EPS beat(8)-85.23%
EPS beat(12)1
Avg EPS beat(12)-168.37%
EPS beat(16)1
Avg EPS beat(16)-164.09%
Revenue beat(2)1
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)0.13%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)3.21%
Revenue beat(8)5
Avg Revenue beat(8)0.37%
Revenue beat(12)9
Avg Revenue beat(12)2.65%
Revenue beat(16)13
Avg Revenue beat(16)5.67%
PT rev (1m)-10.48%
PT rev (3m)-10.48%
EPS NQ rev (1m)-51.58%
EPS NQ rev (3m)-64.48%
EPS NY rev (1m)-37.35%
EPS NY rev (3m)-41.64%
Revenue NQ rev (1m)-4.94%
Revenue NQ rev (3m)-12.86%
Revenue NY rev (1m)-3.7%
Revenue NY rev (3m)-3.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.26
P/S 1.37
P/FCF 48.41
P/OCF 30.42
P/B N/A
P/tB N/A
EV/EBITDA 9.24
EPS(TTM)-0.17
EYN/A
EPS(NY)1.08
Fwd EY12.1%
FCF(TTM)0.18
FCFY2.07%
OCF(TTM)0.29
OCFY3.29%
SpS6.5
BVpS-2.21
TBVpS-6.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.46%
ROE N/A
ROCE 23.8%
ROIC 18.81%
ROICexc 20.35%
ROICexgc 125.36%
OM 21.52%
PM (TTM) N/A
GM 76.81%
FCFM 2.84%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 40.17
Debt/EBITDA 4.25
Cap/Depr 36.24%
Cap/Sales 1.68%
Interest Coverage 1.64
Cash Conversion 17.26%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.84
Altman-Z -0.63
F-Score4
WACC10.81%
ROIC/WACC1.74
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
EPS Next Y542%
EPS Next 2Y257.73%
EPS Next 3Y169.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%
Revenue Next Year-3.26%
Revenue Next 2Y0.04%
Revenue Next 3Y5.88%
Revenue Next 5YN/A
EBIT growth 1Y14.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year538.64%
EBIT Next 3Y104.69%
EBIT Next 5YN/A
FCF growth 1Y-77.08%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-74.45%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%